Lee & Poh Partnership

Malaysia

Analysis

Overview

Lee & Poh Partnership is a corporate and commercial law firm with expertise across a broad spectrum of practice areas. The firm offers equity fundraising through initial public offerings, private investments and equity crowdfunding, in addition to mergers and acquisitions, joint ventures, agreement draughting and review, and employee share-option schemes. The firm provides legal counsel to clients from industries such as healthcare, technology, consumer goods, real estate, manufacturing, energy, and food and beverages originating from jurisdictions including Malaysia, Singapore, China, the US and the UAE. Partner Zuan Yin (Spring) Poh is a key contact. The firm welcomed dispute resolution senior associate Samantha Au from Tuang Chu & Co in January 2025. In September 2024, senior associate Jia Shern Neoh departed for Gobi Partners, followed by partner Edwin Lee, who left to establish Edwin Lee & Partners in December 2025. Both departing lawyers specialised in corporate, M&A and capital markets work. 

Corporate and M&A

Work highlights 

Advising two private individuals on the RM16.2 million ($3.8 million) disposal of a 60% stake in Drive 2 Digital to iMedia Asia, a subsidiary of Catcha Digital. The ongoing transaction involves simultaneous corporate restructuring to acquire five companies in social media marketing. The deal strengthens Catcha Digital's automotive digital media presence through D2D's portfolio of brands including Automachi, Auto123, Careta and Mekanika, which collectively reach 1 million unique monthly visitors. 

Advised Elite Organic in its acquisition by DKSH Performance Materials. The transaction involved the sale of a 30-year-old Malaysian specialty ingredients supplier to the Swiss-listed market expansion services provider, strengthening DKSH's position in pharmaceutical, food and nutraceutical sectors across Asia Pacific. The deal included comprehensive due diligence support and negotiation of definitive agreements, expanding DKSH's capabilities in Malaysia and Singapore's life science industries.